Stage II | Stage III | t | P value | |
---|---|---|---|---|
N | 29 | 33 | – | – |
VBL (ml) | 689 ± 249 | 950 ± 313 | − 3.598 | 0.001 |
VAF (ml) | 2875 ± 1247 | 2243 ± 1199 | 2.031 | 0.047 |
LR (ml/min) | 18.0 ± 8.4 | 12.1 ± 6.0 | 3.189 | 0.002 |
PVD | ||||
Preoperation (%) | 28.1 ± 18.4 | 56.5 ± 19.7 | − 5.821 | < 0.001 |
Postoperation (%) | -3.2 ± 6.2 | 13.3 ± 10.9 | − 7.438 | < 0.001 |
3-month follow-up (%) | 1.7 ± 15.3 | 20.4 ± 16.6 | − 4.576 | < 0.001 |